Viewing nowIbandronate Sodium Hydrate 150 mg Tablets
Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
International Pharmaceutical Co., Ltd.

MFDS item code 201303270 · Approved 2013.02.01 · Insurance code 643703610
Treatment of osteoporosis in postmenopausal women
This medication is used to treat osteoporosis, which is common in postmenopausal women. Osteoporosis is a condition where bones become weak and can break easily, and this drug helps maintain bone health and reduce bone loss. It helps decrease the risk of fractures and improve bone strength. Therefore, it is effective for the treatment of postmenopausal osteoporosis.
Take 1 tablet once a month, regularly on the same morning each month, with a sufficient amount of water at least 1 hour before consuming food, beverages (other than water), or any other oral medications or dietary supplements (including calcium): - This medicine must be swallowed with a sufficient amount (180-240ml) of water while standing or sitting upright, and you must not lie down for 60 minutes after taking it. - Mineral water may reduce the absorption of this medicine, so take it with plain water. - To prevent esophageal ulcers, do not chew or suck the tablet. If a patient forgets to take the medicine on the scheduled dosing day - If 8 days or more remain until the next scheduled dose, take 1 tablet the morning after realizing that the dose was missed, and thereafter take 1 tablet each month on the originally scheduled dosing day. - If 7 days or fewer remain until the next scheduled dose, take 1 tablet on the next scheduled dosing day, and thereafter continue taking 1 tablet each month on the originally scheduled dosing day. - Do not take 2 tablets in the same week. Patients whose dietary intake is inadequate should supplement with calcium or vitamin D, etc. Patients with hepatic impairment No dose adjustment is required. Patients with renal impairment No dose adjustment is required for patients with mild or moderate renal impairment whose creatinine clearance is 30mL/min or higher. Use of this medicine is not recommended in patients with creatinine clearance below 30mL/min, as clinical experience is insufficient. Older adults No dose adjustment is required.
Efficacy and safety in children 18 years of age or younger have not been studied.
This medication should not be used in certain patients. For example, those who are allergic to this drug or its components, patients with untreated hypocalcemia, individuals who cannot remain upright or sit for more than 60 minutes, those with esophageal dysfunction that prevents food from descending properly, and individuals with genetic issues like lactose intolerance should not take this medication. In patients with severe renal failure, this drug should be administered with caution, and it is essential to consult with a doctor before use. When taking this medication, gastrointestinal discomfort, nausea, abdominal pain, and diarrhea may occur. Headache, myalgia, arthralgia, and rash have also been reported. Some patients may temporarily experience flu-like symptoms, but these are generally mild and resolve without treatment. Serious esophageal issues such as esophagitis, esophageal ulcers, and dysphagia may occur, so it is crucial to remain upright or sitting for at least 60 minutes after taking the medication, and if there is pain or discomfort while swallowing, the medication should be stopped immediately and medical advice should be sought. This medication may be hindered in its absorption when taken with calcium, milk, or antacids, so it is important not to consume food or other drugs for at least one hour after taking it. Rare side effects such as osteonecrosis of the jaw have been reported, so it is advisable to have a dental examination before starting this medication and to avoid excessive dental treatment during its use. Also, long-term use of this medication may rarely lead to atypical fractures of the femur or other bones, so if there is pain in the thigh or groin, it is important to consult a doctor. It is advisable not to take this medication during pregnancy or breastfeeding, and its safety in children under 18 has not been established. If any adverse reactions or uncomfortable symptoms occur while taking this medication, consult with healthcare professionals immediately.
Dyspepsia, nausea, abdominal pain, diarrhea, bloating, gastroesophageal reflux disease, headache, influenza-like illness, fatigue, myalgia, arthralgia, rash, gastritis, esophagitis, muscle cramps, musculoskeletal pain, musculoskeletal stiffness, dysphagia, vomiting, esophageal ulcer, stricture, dizziness, low back pain, duodenitis, hypersensitivity, angioedema, facial swelling, urticaria, uveitis, scleritis, osteonecrosis of the jaw and external auditory canal, anaphylaxis, shock, worsening of asthma, Stevens-Johnson syndrome, erythema multiforme, vesicular dermatitis, atypical femoral shaft and subtrochanteric fractures, atypical iliac fracture, visual paresthesia, asthenia, pruritus
Not everyone experiences these, and they can vary from person to person.
This medication can be sensitive to air and moisture, so it must be stored in a tightly closed container. The storage temperature should be kept between 1°C and 30°C at room temperature, which helps maintain the effectiveness of the drug for a long time.
White rectangular film-coated tablet
1 tablet/PTP
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowIbandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
International Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Jeil Pharmaceutical Co., Ltd.
Ibandronate Sodium Monohydrate 3.375mg
Solution · Prescription medication
Jeil Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Chodang Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Ajou Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Aliko Pharmaceutical Co., Ltd.

Ibandronate Sodium Monohydrate 168.75mg
Tablet · Prescription medication
Teragen Etex Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.